TB Alliance Launches First Clinical Trial of a Novel TB Drug Regimen
· First clinical trial to test multiple new TB drugs in combination · Potential for one TB drug regimen to
News
News
TB Alliance Elects Four New Stakeholders
The TB Alliance is delighted to announce the election of four new organizational members of its Stakeholders Association. We welcome
News
David Brennan of AstraZeneca says public sector crucial to drug research
AstraZeneca’s chief executive will this week urge ministers to work with the pharmaceutical industry to share the risks and costs
News
FDA awards nearly $3 million for TB research
The U.S. Food and Drug Administration today announced the award of $2.9 million to support six research projects that will
News
Regulatory Conference Shows The Way Forward From Lessons Learnt In The Past
The 4th Open Forum Conference was held in Addis Ababa, Ethiopia on 18th and 19th August to address key issues
News
New Potential TB Drugs to be Investigated Against Multiple Neglected Diseases
[New York, United States and Geneva, Switzerland, July 7, 2010] The Global Alliance for TB Drug Development (TB Alliance) and
News
Anti-TB compounds could fight neglected diseases
Compounds being developed against tuberculosis also show promise against deadly tropical diseases threatening millions of people, two not-for-profits groups said
News
TB TREATED LIKE OTHER RESPIRATORY DISEASES IN FUTURE
Better drugs and understanding should see tuberculosis treated like any other respiratory disease in future, the TB Alliance said in
News
European Parliamentarians Gather in Spain to Support New Tools for Neglected Disease
Members of Parliament from Spain and other European nations, along with international activists, researchers and NGOs met at the Spanish
News
Lancet Article Highlights Hope in the Tuberculosis Drug Development Pipeline
According to a paper published today in The Lancet, there is unprecedented progress in the development of the global tuberculosis